← Back to headlines
CRISPR Therapeutics (CRSP) Reports Q1 2026 Results
CRISPR Therapeutics AG (CRSP) has released its financial results for the first quarter of 2026, detailing its performance and operational updates.
23 May, 04:49 — 23 May, 04:49
Sources
Showing 1 of 1 sources
